EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mast cell-derived MIF Polarizes Th17 cells to drive lung adenocarcinoma progression

Qianqian Peng, Xiong Ye, Xingyi Xu, Jinghan Song, Zhengfeng Yang, Hui Xiao

Cancer Immunology, Immunotherapy · 14.03.2026 · 75 (4)

DOI: 10.1007/s00262-026-04358-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 14.03.2026. Verfasst von Qianqian Peng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Th17 Cells, Mast Cells, Lung Neoplasms, Macrophage Migration-Inhibitory Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, the Key Technologies R&D Program of Songjiang District, Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Th17 CellsMast CellsLung NeoplasmsMacrophage Migration-Inhibitory FactorsAdenocarcinoma of LungIntramolecular OxidoreductasesAnimalsHumansMiceTumor MicroenvironmentDisease ProgressionMaleFemaleInterleukin-17Retrospective Studies

Stichwörter der Autor:innen

Lung adenocarcinomaMIFMast cellTh17 cellTumor microenvironment

Substanzen

Macrophage Migration-Inhibitory FactorsIntramolecular OxidoreductasesMIF protein, humanInterleukin-17

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • School of Clinical Medicine, Shanghai University of Medicine & Health Sciences, Shanghai, China.
  • Precision Research Center for Refractory Diseases, Shanghai Jiao Tong University Pioneer Research Institute for Molecular and Cell Therapies, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine,…
  • State Key Laboratory of Innovative Immunotherapy, School of Pharmaceutical Sciences, Shanghai Jiao Tong University, Shanghai, 200240, China. zhengfeng.yang@shgh.cn.
  • Department of Respiratory and Critical Care Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. xiaohui771210@163.com.

Förderung

  • National Natural Science Foundation of China
  • the Key Technologies R&D Program of Songjiang District, Shanghai

Zitieren

APA

Peng, Q., Ye, X., Xu, X., Song, J., Yang, Z., & Xiao, H. (2026). Mast cell-derived MIF Polarizes Th17 cells to drive lung adenocarcinoma progression. Cancer Immunology, Immunotherapy, 75(4). https://doi.org/10.1007/s00262-026-04358-3

Vancouver

Peng Q, Ye X, Xu X, Song J, Yang Z, Xiao H. Mast cell-derived MIF Polarizes Th17 cells to drive lung adenocarcinoma progression. Cancer Immunology, Immunotherapy. 2026;75(4). doi:10.1007/s00262-026-04358-3

BibTeX
@article{Peng2026,
  author = {Peng, Qianqian and Ye, Xiong and Xu, Xingyi and Song, Jinghan and Yang, Zhengfeng and Xiao, Hui},
  title = {Mast cell-derived MIF Polarizes Th17 cells to drive lung adenocarcinoma progression},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2026},
  volume = {75},
  number = {4},
  doi = {10.1007/s00262-026-04358-3}
}
Kostenlos starten →